Susquehanna International Group
XGN icon

Susquehanna International Group’s Exagen XGN Stock Holding History

Susquehanna International Group’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-71,000
Closed -$170K – 13604
2022
Q4 		$170K Sell
71,000
-11,000
-13% -$28.2K ﹤0.01% 10347
2022
Q3 		$222K Sell
82,000
-52,400
-39% -$292K ﹤0.01% 10574
2022
Q2 		$771K Buy
134,400
+13,100
+11% +$76.3K ﹤0.01% 7172
2022
Q1 		$974K Buy
+121,300
New +$1.05M ﹤0.01% 7190

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Susquehanna International Group's XGN Position: Q1 2026 in Review

Susquehanna International Group reduced its Exagen (XGN) stake by 92% in Q1 2026, selling an estimated $1.07M and leaving 25,476 shares worth $76.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12477.

Susquehanna International Group first reported a position in XGN in Q2 2022 and has held it in 4 quarters since. The position peaked at $2.22M in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Susquehanna International Group held 25,476 shares of Exagen worth $76.4K as of Q1 2026.
  • Susquehanna International Group sold 277,837 Exagen shares in Q1 2026, an estimated $1.07M.
  • Exagen made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12477 holding.
  • Susquehanna International Group first reported a position in Exagen in Q2 2022 and has held it in 4 quarters since.
  • Susquehanna International Group's Exagen position peaked at $2.22M in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.